Literature DB >> 11419443

Deep venous thrombosis and thalidomide therapy for multiple myeloma.

K Osman, R Comenzo, S V Rajkumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11419443     DOI： 10.1056/NEJM200106213442516

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

Review 1.  Multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Curr Probl Cancer       Date:  2009 Jan-Feb       Impact factor: 3.187

2.  Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Authors:  Sigurdur Y Kristinsson; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Sam Schulman; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

Review 3.  Cardiovascular Complications Associated with Multiple Myeloma Therapies: Incidence, Pathophysiology, and Management.

Authors:  Vivek G Patel; Robert F Cornell
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

4.  Thromboprophylaxis in multiple myeloma: is the evidence there?

Authors:  Sigurdur Yngvi Kristinsson; Ola Landgren
Journal:  Expert Rev Anticancer Ther       Date:  2012-03       Impact factor: 4.512

5.  Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

Authors:  S Y Kristinsson; L Goldin; I Turesson; M Hultcrantz; M Björkholm; O Landgren
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

Review 6.  Management of thalidomide toxicity.

Authors:  Irene M Ghobrial; S Vincent Rajkumar
Journal:  J Support Oncol       Date:  2003 Sep-Oct

Review 7.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

8.  Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.

Authors:  Santosh Kesari; David Schiff; Lisa Doherty; Debra C Gigas; Tracy T Batchelor; Alona Muzikansky; Alison O'Neill; Jan Drappatz; Alice S Chen-Plotkin; Naren Ramakrishna; Stephanie E Weiss; Brenda Levy; Joanna Bradshaw; Jean Kracher; Andrea Laforme; Peter McL Black; Judah Folkman; Mark Kieran; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2007-04-23       Impact factor: 12.300

9.  Thromboembolic events with lenalidomide-based therapy for multiple myeloma.

Authors:  Smitha Patiyil Menon; S Vincent Rajkumar; Martha Lacy; Patrizia Falco; Antonio Palumbo
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

Review 10.  New therapies in multiple myeloma.

Authors:  F Merchionne; F Perosa; F Dammacco
Journal:  Clin Exp Med       Date:  2007-10-03       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.